UPDATE: Baird Downgrades Signify Health Inc (SGFY) to Neutral

Baird analyst Vikram Kesavabhotla downgraded Signify Health Inc (NYSE: SGFY) from Outperform to Neutral with a price target of $24.00 (from $30.00).

The analyst comments "While we still believe SGFY has an innovative model with compelling growth opportunities, we see a number of uncertainties emerging that may limit NTM upside. In particular, we discuss the limited visibility into ECS progression, the emergence of a regulatory overhang around HCS, and F22 expectations that may be high. Each of these factors on a standalone basis is perhaps less significant, but in aggregate may limit enthusiasm around the shares at the current valuation. We therefore find it more prudent to move to the sidelines."

For an analyst ratings summary and ratings history on Signify Health Inc click here. For more ratings news on Signify Health Inc click here.

Shares of Signify Health Inc closed at $21.44 yesterday.

You May Also Be Interested In

• Nebius Group (NBIS) PT Raised to $300 at Compass Point
• North American Construction Group (NOA:CN) (NOA) PT Raised to Cdn$24 at BMO Capital
• Boyd Group Services Inc (BYD:CN) (BYDGF) PT Lowered to Cdn$190 at BMO Capital